Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Planning Another Patient Group To Boost Involvement

Executive Summary

Patient Engagement Collaborative expected to invite stakeholders to discuss how patient interaction with FDA can improve.

You may also be interested in...



US FDA's Patient Affairs Office Is An Office … In Spirit

Rachel Sherman says agency is creating patient affairs staff, but will not undergo reorganization to create an official office.

Patient Advocates Continue To Push US FDA For Central Office

Will a meeting with the agency's new principal deputy commissioner help assure creation of new access point for patient engagement?

US FDA Patient Affairs Office Could Accelerate Involvement With 'Central Entry Point'

FDA floats idea of central office to coordinate patient engagement for symbolic as well as practical reasons.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

PS120644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel